IL22 and chronic obstructive pulmonary disease: IL-22 has been clinically shown in COPD murine models to increase mRNA expression and protein expression in response to chronic CS exposure, with IL-22-deficient models presenting improved lung function and no airway remodeling when compared to the IL-22 mice [74].